Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Net revenue	$ 751,944	$ 681,056
Cost of sales (exclusive of amortization shown separately below)	301,304	276,001
Amortization of acquired intangible assets	11,979	13,436
Total cost of sales	313,283	289,437
Gross profit	438,661	391,619
Operating expenses:
Selling, general and administrative	158,989	167,440
Research and development	54,533	48,033
Amortization of acquired intangible assets	8,243	5,044
Total operating expenses	221,765	220,517
Income from operations	216,896	171,102
Other income (loss), net:
Interest income	117	449
Interest expense	(6,842)	(10,992)
Loss attributable to equity method investments (note 5)	(2,288)	(6,863)
Other, net (note 13)	7,971	(3,109)
Total other income (loss), net	(1,042)	(20,515)
Income before income taxes	215,854	150,587
Income taxes	37,482	30,439
Net income	$ 178,372	$ 120,148
Basic earnings per share (note 9)	$ 1.23	$ 0.84
Diluted earnings per share (note 9)	1.22	0.83
Dividend declared per share	$ 0.39	$ 0.39
Basic shares outstanding (000's)	144,900	143,719
Diluted shares outstanding (000's)	146,100	145,099
Sleep And Respiratory Care [Member]
Net revenue	$ 659,801	$ 594,201
Cost of sales (exclusive of amortization shown separately below)	268,990	246,416
Operating expenses:
Amortization of acquired intangible assets	1,955	2,251
Software As A Service [Member]
Net revenue	92,143	86,855
Cost of sales (exclusive of amortization shown separately below)	32,314	29,585
Operating expenses:
Amortization of acquired intangible assets	$ 10,024	$ 11,185